Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Tacrolimus and Danazol Combination As a Second-Line Therapeutic Strategy for Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Prospective, Randomized, Multicenter, Open-Label Study

Zhuo-Yu An, Yun He, Xiao-lu Zhu, Qiu-Sha Huang, Jin Wu, Haixia Fu, Yuan-Yuan Zhang, Ying-jun Chang, Xiangyu Zhao, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 2582.

https://doi.org/10.1182/blood-2023-188139

Published: 2023

Journal Articles

Oligoclonal Bands in CSF May be Associated with Chronic Graft Versus Host Disease after Haploidentical Hematopoietic Stem Cell Transplantation

Chen Zhao, Haixia Fu, Yuhong Chen, Yuanyuan Zhang, Jing-Zhi Wang, Xiao-Dong Mo, Huan Chen, Yu Wang, Ying-Jun Chang, Lanping Xu, Kai-yan Liu, Xiao-Jun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 7012.

https://doi.org/10.1182/blood-2023-184639

Published: 2023

Journal Articles

A Completely Oral Regimen Including Oral Etoposide As Cytoreductive Chemotherapy Combined with All Trans Retinoic Acid and Oral Arsenic for Induction Therapy in Patients with High-Risk APL：Comparable to Intravenous Cytoreductive Therapy

Feifei Tang, Wen-Bing Duan, Xiao-Hong Liu, Sheng-Ye Lu, Xiao-Su Zhao, Ya-Zhen Qin, Jin-Song Jia, Jing Wang, Li-Zhong Gong, Qian Jiang, Zhao Ting, Hong-Xia Shi, Ying-Jun Chang, Xiao-Jun Huang, Hao Jiang

Blood (2023) 142 (Supplement 1): 4288.

https://doi.org/10.1182/blood-2023-188657

Published: 2023

Journal Articles

Comparison of Safety and Efficacy between Venetoclax Combined with CAG (cytarabine, aclarubicin, G-CSF) Regimen and CAG Regimen Alone in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Wen-Jing Yu, Ying Wu, Qi Chen, Xiaolu Zhu, Xu-Ying Pei, Jin-Song Jia, Jing Wang, Xiao-Su Zhao, Ying-Jun Chang, Yue-Yun Lai, Hong-Xia Shi, Guo-Rui Ruan, Ya-Zhen Qin, Xiao-Hong Liu, Xiao Jun Huang, Hao Jiang

Blood (2023) 142 (Supplement 1): 1525.

https://doi.org/10.1182/blood-2023-184665

Published: 2023

Journal Articles

G-CSFR Is a Checkpoint of Natural Killer Cells Against Tumor

Xunhong Cao, Ting-Ting Han, Ming Zhao, Xie Juan, Ying-Jun Chang, Xiao-Jun Huang, Xiangyu Zhao

Blood (2023) 142 (Supplement 1): 3923.

https://doi.org/10.1182/blood-2023-182511

Published: 2023

Journal Articles

A Prognostic Score Model for Relapsed/Refractory Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Yue Jin, Haixia Fu, Yuhong Chen, Yuanyuan Zhang, Jing-Zhi Wang, Xiao-Dong Mo, Huan Chen, Yao Chen, Yu Wang, Ying-Jun Chang, Lanping Xu, Kai-yan Liu, Xiao-Jun Huang, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 4237.

https://doi.org/10.1182/blood-2023-184701

Published: 2023

Journal Articles

Risk Factors for Positive Posttransplantation Measurable Residual Disease in Patients with Acute Lymphoblastic Leukemia

Yuewen Wang, Guomei Fu, Lanping Xu, Yu Wang, Yi-Fei Cheng, Yuanyuan Zhang, Xiaohui Zhang, Yanrong Liu, Kaiyan Liu, Xiao-Jun Huang, Ying-Jun Chang

Blood (2023) 142 (Supplement 1): 7046.

https://doi.org/10.1182/blood-2023-182572

Published: 2023

Journal Articles

Anti-PD-1 Antibody (Sintilimab) Plus Decitabine As First Line Treatment for Patients with Higher-Risk Myelodysplastic Syndrome (MDS): Primary Results from a Single-Arm,Open-Label,Phase II Study

Jing Wang, Siqi Li, Hao Jiang, Ying-Jun Chang, Xiao-su Zhao, Jinsong JIA, Xiaolu Zhu, Lizhong Gong, Xiaohong Liu, Wen-Jing Yu, Xiaojun Huang

Blood (2023) 142 (Supplement 1): 4600.

https://doi.org/10.1182/blood-2023-174600

Published: 2023

Journal Articles

A Novel Risk Stratification Model for Cytogenetically Normal Acute Myeloid Leukemia with FLT3-ITD Mutation

Lei-Ming Cao, Ya-Lan Zhou, Ming-Yue Zhao, Li-Xia Liu, Hao Jiang, Ying-Jun Chang, Qian Jiang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Guo-Rui Ruan

Blood (2022) 140 (Supplement 1): 3218–3219.

https://doi.org/10.1182/blood-2022-169126

Published: 2022

Journal Articles

Single-Cell Immune Landscape of Measurable Residual Disease in AML after Allogeneic Hematopoietic Stem Cell Transplantation

Xiao-Dong Mo, Weilong Zhang, Guomei Fu, Ying-Jun Chang, Xiao-hui Zhang, Lanping Xu, Yu Wang, Chen-Hua Yan, Meng-Zhu Shen, Qiu-Xia Wei, Changjian Yan, Xiao-jun Huang

Blood (2022) 140 (Supplement 1): 12908–12909.

https://doi.org/10.1182/blood-2022-165909

Published: 2022

Journal Articles

Distinct Immune Homeostasis Remodeling Patterns after HLA-Matched and Haploidentical Transplantation

Huidong Guo, Liping Guo, Bixia Wang, Ming Wang, Yan Hong, Xiao-Dong Mo, Yuqian Sun, Yuan-Yuan Zhang, Zhidong Wang, Jun Kong, Chen-Hua Yan, Yu Wang, Lan-Ping Xu, Xiaohui Zhang, Ying-Jun Chang, Xiao-Jun Huang

Blood (2022) 140 (Supplement 1): 4479–4481.

https://doi.org/10.1182/blood-2022-162906

Published: 2022

Journal Articles

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Si-Qi Li, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Meng Lv, Fei-Fei Tang, Xiao-Dong Mo, Yan-Rong Liu, Kai-Yan Liu, Ying-Jun Chang, Xiao-Jun Huang

Blood (2022) 140 (5): 516–520.

https://doi.org/10.1182/blood.2021014604

Published: 2022

Includes: Supplemental data

Journal Articles

All- trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP

Ye-Jun Wu, Hui Liu, Qiao-Zhu Zeng, Yi Liu, Jing-Wen Wang, Wen-Sheng Wang, Jia-Feng, He-Bing Zhou, Qiu-Sha Huang, Yun He, Hai-Xia Fu, Xiao-Lu Zhu, Qian Jiang, Hao Jiang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2022) 139 (3): 333–342.

https://doi.org/10.1182/blood.2021013393

Published: 2022

Includes: Supplemental data

Journal Articles

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

Blood (2021) 138 (Supplement 1): 13.

https://doi.org/10.1182/blood-2021-152111

Published: 2021

Journal Articles

All-Trans Retinoic Acid Plus Low-Dose Rituximab Vs Low-Dose Rituximab in Corticosteroid-Resistant or Relapsed ITP

Ye-Jun Wu, Hui Liu, Qiao-Zhu Zeng, Yi Liu, Jing-Wen Wang, Wen-Sheng Wang, Jia Feng, He-Bing Zhou, Qiu-Sha Huang, Hai-Xia Fu, Xiao-Lu Zhu, Yun He, Hao Jiang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2021) 138 (Supplement 1): 15.

https://doi.org/10.1182/blood-2021-149527

Published: 2021

Journal Articles

A Clinical Study of 15 Acute Leukemia Patients with Plasmacytoid Dendritic Cells Expansion

Ya-Lan Zhou, Yan Wei, Xiaohong Liu, Jing Wang, Jinsong Jia, Hong-Xia Shi, Ying-Jun Chang, Xiao-Su Zhao, Yan-Rong Liu, Guo-Rui Ruan, Xiao-Jun Huang, Hao Jiang

Blood (2021) 138 (Supplement 1): 4468.

https://doi.org/10.1182/blood-2021-149623

Published: 2021

Journal Articles

Prevalence and Risk Factors of Antibodies to Class I and II Human Leukocyte Antigens in Haploidentical Allograft Candidates: A Prospective Study on 3805 Subjects

Ning Ma, Lan-Ping Xu, Xiaohui Zhang, Yu Wang, Huan Chen, Wei Han, Yuqian Sun, Chenhua Yan, Fei-Fei Tang, Xiaodong Mo, Yan-Rong Liu, Kaiyan Liu, Xiao Jun Huang, Ying-Jun Chang

Blood (2021) 138 (Supplement 1): 2880.

https://doi.org/10.1182/blood-2021-149088

Published: 2021

Journal Articles

Treatment Outcome and Efficacy of Therapeutic Plasma Exchange for Transplant-Associated Thrombotic Microangiopathy in a Real-World Large Cohort Study

Li-Ping Yang, Peng Zhao, Ye-Jun Wu, Hai-Xia Fu, Yun He, Xiao-Dong Mo, Meng Lv, Feng-Rong Wang, Chen-Hua Yan, Yu-Hong Chen, Ying-Jun Chang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2021) 138 (Supplement 1): 1013.

https://doi.org/10.1182/blood-2021-149373

Published: 2021

Journal Articles

Machine-Learning Based Early Warning System for Prediction for Disseminated Intravascular Coagulation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Multicenter Study

Blood (2021) 138 (Supplement 1): 2113.

https://doi.org/10.1182/blood-2021-150437

Published: 2021

Journal Articles

Development and Validation of a Prognostic Model for Transplant-Associated Thrombotic Microangiopathy Following Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2020) 136 (Supplement 1): 16–17.

https://doi.org/10.1182/blood-2020-138408

Published: 2020

NARROW

Tacrolimus and Danazol Combination As a Second-Line Therapeutic Strategy for Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Prospective, Randomized, Multicenter, Open-Label Study

Oligoclonal Bands in CSF May be Associated with Chronic Graft Versus Host Disease after Haploidentical Hematopoietic Stem Cell Transplantation

A Completely Oral Regimen Including Oral Etoposide As Cytoreductive Chemotherapy Combined with All Trans Retinoic Acid and Oral Arsenic for Induction Therapy in Patients with High-Risk APL：Comparable to Intravenous Cytoreductive Therapy

Comparison of Safety and Efficacy between Venetoclax Combined with CAG (cytarabine, aclarubicin, G-CSF) Regimen and CAG Regimen Alone in Patients with Relapsed or Refractory Acute Myeloid Leukemia

G-CSFR Is a Checkpoint of Natural Killer Cells Against Tumor

A Prognostic Score Model for Relapsed/Refractory Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Stem Cell Transplantation

Risk Factors for Positive Posttransplantation Measurable Residual Disease in Patients with Acute Lymphoblastic Leukemia

Anti-PD-1 Antibody (Sintilimab) Plus Decitabine As First Line Treatment for Patients with Higher-Risk Myelodysplastic Syndrome (MDS): Primary Results from a Single-Arm,Open-Label,Phase II Study

A Novel Risk Stratification Model for Cytogenetically Normal Acute Myeloid Leukemia with FLT3-ITD Mutation

Single-Cell Immune Landscape of Measurable Residual Disease in AML after Allogeneic Hematopoietic Stem Cell Transplantation

Distinct Immune Homeostasis Remodeling Patterns after HLA-Matched and Haploidentical Transplantation

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

All- trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

All-Trans Retinoic Acid Plus Low-Dose Rituximab Vs Low-Dose Rituximab in Corticosteroid-Resistant or Relapsed ITP

A Clinical Study of 15 Acute Leukemia Patients with Plasmacytoid Dendritic Cells Expansion

Prevalence and Risk Factors of Antibodies to Class I and II Human Leukocyte Antigens in Haploidentical Allograft Candidates: A Prospective Study on 3805 Subjects

Treatment Outcome and Efficacy of Therapeutic Plasma Exchange for Transplant-Associated Thrombotic Microangiopathy in a Real-World Large Cohort Study

Machine-Learning Based Early Warning System for Prediction for Disseminated Intravascular Coagulation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Multicenter Study

Development and Validation of a Prognostic Model for Transplant-Associated Thrombotic Microangiopathy Following Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only